Hipodermokliza
Hypodermoclysis

a safe, comfortable, functional and low-cost method of parenteral hydration

Authors

  • Jožica Jelen-Jurič Onkološki inštitut, Ljubljana
  • Jernej Benedik Onkološki inštitut, Ljubljana

Keywords:

Hypodermoclysis, palliative care

Abstract

Hipodermoklizo so v 40. letih prejšnjega stoletja začeli uporabljati v pediatriji za zdravljenje dehidracije. Je varen, udoben in poceni postopek nadomeščanja tekočin in dajanja nekaterih zdravil. Uporabna je predvsem v nenujnih okoliščinah. Njeno uporabo priporočajo tudi v zadnjih smernicah ESPEN. Subkutano lahko dajemo tudi številna zdravila, nekatere antibiotike, opisano je tudi dajanje furosemida. Pomembna je izbira pravilne raztopine (vsebovati mora sol). Glavne omejitve predstavlja omejena količina tekočine, ki jo lahko apliciramo v enem dnevu (do 3 litre), in lokalni edem. Je ena od metod izbora za dajanje zdravil v paliativni oskrbi (poleg dajanja skozi usta).

Abstract (Eng)

In clinical practice, hypodermoclysis was first used in the forties of the earlier century in the treatment of pediatric patients for dehydration. It is a safe, comfortable and low-cost method for replacing an excessive loss of body water as well as for administering some drugs. It is primarily used in non-urgent care. Moreover, its application was also recommended in the last edition ESPEN guidelines. The method can be used also for subcutaneous administration of various drugs, e.g. antibiotics and also furosemide. It is important to select an appropriate fluid (it has to contain salt). Major disadvantages of the method are limited quantity of the fluid to be administered per day (3 liters) and local oedema. Hypodermoclysis is, in addition to oral administration, also a method of choice for drug administration in palliative care of patients.

Published

2009-12-15

How to Cite

Jelen-Jurič, J., & Benedik, J. (2009). Hypodermoclysis: a safe, comfortable, functional and low-cost method of parenteral hydration. Onkologija : Slovenian Journal of Oncology, 13(2), 120–123. Retrieved from https://revijaonkologija.si/Onkologija/article/view/337

Issue

Section

Review Article